3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Motor Activity
12
Colonic Neoplasms
8
Colorectal Neoplasms
7
Rectal Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Smoking Cessation
2
Postoperative Complications
2
Insulin Resistance
2
Frailty
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Urologic Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Patient Preference
1
Pancreatitis, Chronic
1
Pain
1
Obesity
1
Nutrition Disorders
1
Metabolic Syndrome
1
Interventions
Cyclophosphamide
344
Cytarabine
281
fludarabine phosphate
201
Methotrexate
185
Filgrastim
159
Busulfan
147
Etoposide
135
Peripheral Blood Stem Cell Transplantation
133
fludarabine
127
Rituximab
119
Radiotherapy
111
Vincristine
102
Cyclosporine
98
Daunorubicin
96
Antilymphocyte Serum
94
Dexamethasone
91
Tacrolimus
85
Mycophenolic Acid
85
Whole-Body Irradiation
80
Melphalan
79
Idarubicin
67
Mercaptopurine
66
Imatinib Mesylate
66
Granulocyte Colony-Stimulating Factor
65
Azacitidine
65
Methylprednisolone
59
Prednisone
58
Doxorubicin
58
Clofarabine
54
sargramostim
53
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Leukemia
×
Preoperative Exercise
×
Clear all
NCT05649371
2022-12-14
Multiphasic Prehab Allo-HSCT
University of Calgary
Phase NA
Unknown
60 enrolled